

Health Care: Drugs
Icagen Inc. (ICGN: NASDAQ)
$5.99 0.00 | 0.00%
07/23/12 - 12:15 AM ET
Portfolios with ICGN
Latest ICGN Headlines from TheStreet
More Financial News for ICGN
Press Releases for ICGN
- Pfizer Announces Expiration Of Subsequent Offering Period And Completion Of Tender Offer For Shares Of Icagen, Inc. - Business Wire 09.20.11 | 08:09 am
- Pfizer Extends Subsequent Offering Period Of Tender Offer To Acquire Icagen, Inc. - Business Wire 09.13.11 | 08:09 am
- Pfizer Announces Successful Completion Of Initial Cash Tender Offer For Outstanding Shares Of Icagen, Inc. And Commencement Of Subsequent Offering Period - Business Wire 09.06.11 | 08:09 am
- Pfizer Extends Tender Offer To Acquire Icagen, Inc. - Business Wire 09.02.11 | 08:09 am
- Merlin Nexus And New Leaf Venture Partners Comment On Extension Of Tender Offer Deadline In Conjunction With Pfizer's Proposed $56 Million Acquisition Of Icagen - PR Newswire 09.01.11 | 10:09 am
- Pfizer Extends Tender Offer To Acquire Icagen, Inc. - Business Wire 09.01.11 | 08:09 am
- Merlin Nexus And New Leaf Venture Partners Continue To Contest Proposed $56 Million Acquisition Of Icagen By Pfizer - PR Newswire 08.25.11 | 08:08 am
- Bull & Lifshitz, LLP Announces Investigation Of Icagen, Inc. - Business Wire 07.21.11 | 04:07 pm
- Ryan & Maniskas, LLP Announces Investigation Of Icagen, Inc. - Business Wire 07.21.11 | 10:07 am
- Murray Frank LLP Investigates Icagen, Inc. - Business Wire 07.20.11 | 10:07 pm
See All Press Releases
Partner Headlines for ICGN